Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Dec 07, 2022 6:02pm
214 Views
Post# 35157646

RE:RE:RE:RE:RE:RE:RE:Impressive panic

RE:RE:RE:RE:RE:RE:RE:Impressive panicThis story isn't over yet, but you cannot blame the advocates for convincing you to make a decision for yourself.  That's just not right.  Everyone of us have weighed the pros/cons and made the decision to invest, stay invested or sell.  I weighed SPCEO1's logic and institutional knowledge along with many others against what I was observing and decided to go all in.  I really thought we had something.  Now, I've lost a small fortune.  I don't even blame the company really other than the fact that I think they could be preserving the value of the stock by becoming hyper communicative.  In any crisis, the best leaders step up and start overcommunicating, even if it's only partial steps of a stragegy when partial information is available.  This is a crisis for the company at this point.  They need to step up and lead from the front.  They are managing multiple fronts now:  Potential lawsuit, cratering stock price (regulatory, upset investors, lack of potential new investments, loss of credibility with analyst), employees fearing the loss of their jobs and need for HR to reassure staff or layout transition plans, budget constraints that now require an immediately different approach to capital.  The list goes on.  

Adonis wrote: I lost all my money because of him, several times I wanted to sell in the past but his post in favor of paul makes me change my mind.. now that the disaster is here, he disappeared..


<< Previous
Bullboard Posts
Next >>